| Global consensus position statement on the use of testosterone therapy for women SR Davis, R Baber, N Panay, J Bitzer, SC Perez, RM Islam, AM Kaunitz, ... The journal of sexual medicine 16 (9), 1331-1337, 2019 | 315 | 2019 |
| Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and … AHEM Maas, G Rosano, R Cifkova, A Chieffo, D van Dijken, H Hamoda, ... European Heart Journal 42 (10), 967-984, 2021 | 269 | 2021 |
| Menopause and diabetes: EMAS clinical guide R Slopien, E Wender-Ozegowska, A Rogowicz-Frontczak, B Meczekalski, ... Maturitas 117, 6-10, 2018 | 242 | 2018 |
| Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress A Augoulea, A Alexandrou, M Creatsa, N Vrachnis, I Lambrinoudaki Archives of gynecology and obstetrics 286, 99-103, 2012 | 218 | 2012 |
| Pathogenesis of endometriosis: the role of defective ‘immunosurveillance’ G Christodoulakos, A Augoulea, I Lambrinoudaki, V Sioulas, G Creatsas The European Journal of Contraception & Reproductive Health Care 12 (3), 194-202, 2007 | 188 | 2007 |
| Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis P Anagnostis, K Christou, AM Artzouchaltzi, NK Gkekas, N Kosmidou, ... European journal of endocrinology 180 (1), 41-50, 2019 | 181 | 2019 |
| EMAS position statement: management of uterine fibroids FR Pérez-López, L Ornat, I Ceausu, H Depypere, CT Erel, ... Maturitas 79 (1), 106-116, 2014 | 179 | 2014 |
| EMAS position statement: managing women with premature ovarian failure S Vujovic, M Brincat, T Erel, M Gambacciani, I Lambrinoudaki, MH Moen, ... Maturitas 67 (1), 91-93, 2010 | 171 | 2010 |
| Measurable serum markers of oxidative stress response in women with endometriosis IV Lambrinoudaki, A Augoulea, GE Christodoulakos, EV Economou, ... Fertility and sterility 91 (1), 46-50, 2009 | 166 | 2009 |
| EMAS position statement: Vitamin D and postmenopausal health FR Pérez-López, M Brincat, CT Erel, F Tremollieres, M Gambacciani, ... Maturitas 71 (1), 83-88, 2012 | 163 | 2012 |
| Cross-sectional long-term micronutrient deficiencies after sleeve gastrectomy versus Roux-en-Y gastric bypass: a pilot study A Alexandrou, E Armeni, E Kouskouni, E Tsoka, T Diamantis, ... Surgery for Obesity and Related Diseases 10 (2), 262-268, 2014 | 155 | 2014 |
| The role of the oxidative-stress in the endometriosis-related infertility A Augoulea, G Mastorakos, I Lambrinoudaki, G Christodoulakos, ... Gynecological Endocrinology 25 (2), 75-81, 2009 | 153 | 2009 |
| Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide A Cano, P Chedraui, DG Goulis, P Lopes, G Mishra, A Mueck, LM Senturk, ... Maturitas 107, 7-12, 2018 | 148 | 2018 |
| EMAS position statement: predictors of premature and early natural menopause GD Mishra, HF Chung, A Cano, P Chedraui, DG Goulis, P Lopes, ... Maturitas 123, 82-88, 2019 | 147 | 2019 |
| Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement P Anagnostis, SA Paschou, G Mintziori, I Ceausu, H Depypere, ... Maturitas 101, 23-30, 2017 | 136 | 2017 |
| CSF and plasma cytokines at delivery and postpartum mood disturbances F Boufidou, I Lambrinoudaki, J Argeitis, IM Zervas, P Pliatsika, ... Journal of affective disorders 115 (1-2), 287-292, 2009 | 136 | 2009 |
| EMAS position statement: the ten point guide to the integral management of menopausal health M Neves-e-Castro, M Birkhauser, G Samsioe, I Lambrinoudaki, ... Maturitas 81 (1), 88-92, 2015 | 135 | 2015 |
| Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors GA Georgiopoulos, KS Stamatelopoulos, I Lambrinoudaki, M Lykka, ... Hypertension 54 (1), 98-105, 2009 | 135 | 2009 |
| EMAS position statement: non-hormonal management of menopausal vasomotor symptoms G Mintziori, I Lambrinoudaki, DG Goulis, I Ceausu, H Depypere, CT Erel, ... Maturitas 81 (3), 410-413, 2015 | 130 | 2015 |
| Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis? S Rozenberg, N Al-Daghri, M Aubertin-Leheudre, ML Brandi, A Cano, ... Osteoporosis international 31, 2271-2286, 2020 | 125 | 2020 |
